Biogen moves forward with Alzheimer’s drug trial
Biogen moves forward with Alzheimer's drug trial despite mixed results, focusing on tau protein to slow cognitive decline.
Category
Biogen moves forward with Alzheimer's drug trial despite mixed results, focusing on tau protein to slow cognitive decline.